Role of endothelin-1 antagonist; bosentan, against cisplatin-induced nephrotoxicity in male and female rats

Background: Cisplatin (CP) is a chemotherapy drug, with the major side effect of nephrotoxicity. The level of endothelin-1 (ET-1) increases during nephrotoxicity, which is accompanied with vasoconstrictive properties. Bosentan (BOS) is a nonselective ET-1 receptor antagonist, having vasodilatory and...

Full description

Bibliographic Details

Published in:	Advanced Biomedical Research
Main Authors:	Zahra Jokar, Mehdi Nematbakhsh, Maryam Moeini, Ardeshir Talebi
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2015-01-01
Subjects:	Bosentan cisplatin gender nephrotoxicity rat
Online Access:	http://www.advbiores.net/article.asp?issn=2277-9175;year=2015;volume=4;issue=1;spage=83;epage=83;aulast=Jokar